CoChat
Sign Up
Cited by 459

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Trans-ethnic association study of blood pressure determinants in over 750,000 individuals

Understanding Society Scientific Group, Giri, Ayush, International Consortium for Blood Pressure, Blood Pressure-International Consortium of Exome Chip Studies, Million Veteran Program, Hellwege, Jacklyn N., Keaton, Jacob M., Park, Jihwan, Qiu, Chengxiang, Warren, Helen R., Torstenson, Eric S., Kovesdy, Csaba P., Sun, Yan V., Wilson, Otis D., Robinson-Cohen, Cassianne, Roumie, Christianne L., Chung, Cecilia P., Birdwell, Kelly A., Damrauer, Scott M., DuVall, Scott L., Klarin, Derek, Cho, Kelly, Wang, Yu, Evangelou, Evangelos, Cabrera, Claudia P., Wain, Louise V., Shrestha, Rojesh, Mautz, Brian S., Akwo, Elvis A., Sargurupremraj, Muralidharan, Debette, Stéphanie, Boehnke, Michael, Scott, Laura J., Luan, Jian’an, Zhao, Jing-Hua, Willems, Sara M., Thériault, Sébastien, Shah, Nabi, Oldmeadow, Christopher, Almgren, Peter, Li-Gao, Ruifang, Verweij, Niek, Boutin, Thibaud S., Mangino, Massimo, Ntalla, Ioanna, Feofanova, Elena, Surendran, Praveen, Cook, James P., Karthikeyan, Savita, Lahrouchi, Najim, Liu, Chunyu, Sepúlveda, Nuno, Richardson, Tom G., Kraja, Aldi, Amouyel, Philippe, Farrall, Martin, Poulter, Neil R., Laakso, Markku, Zeggini, Eleftheria, Sever, Peter, Scott, Robert A., Langenberg, Claudia, Wareham, Nicholas J., Conen, David, Palmer, Colin Neil Alexander, Attia, John, Chasman, Daniel I., Ridker, Paul M., Melander, Olle, Mook-Kanamori, Dennis Owen, Harst, Pim van der, Cucca, Francesco, Schlessinger, David, Hayward, Caroline, Spector, Tim D., Jarvelin, Marjo-Riitta, Hennig, Branwen J., Timpson, Nicholas J., Wei, Wei-Qi, Smith, Joshua C., Xu, Yaomin, Matheny, Michael E., Siew, Edward E., Lindgren, Cecilia, Herzig, Karl-Heinz, Dedoussis, George, Denny, Joshua C., Psaty, Bruce M., Howson, Joanna M. M., Munroe, Patricia B., Newton-Cheh, Christopher, Caulfield, Mark J., Elliott, Paul, Gaziano, J. Michael, Concato, John, Wilson, Peter W. F., Tsao, Philip S., Velez Edwards, Digna R., Susztak, Katalin, O’Donnell, Christopher J., Hung, Adriana M., Edwards, Todd L.·2019·Nature Genetics
DOI 10.1038/s41588-018-0303-9PMC PMC6365102
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-018-0303-9

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 87

  1. Lawes, C. M. M., Vander Hoorn, S. & Rodgers, A. International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 371, 1513–1518 (2008). · DOI
  2. Lewington, S. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903–1913 (2002). · DOI · Paper page
  3. Muntner, P. et al. Potential U.S. population impact of the 2017 ACC/AHA high blood pressure guideline. J. Am. Coll. Cardiol. 71, 109–118 (2018). · DOI · Paper page
  4. International Consortium for Blood Pressure Genome-Wide Association Studies et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103–109 (2011). · DOI · Paper page
  5. Levy, D. et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 41, 677–687 (2009). · DOI · Paper page
  6. Newton-Cheh, C. et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 41, 666–676 (2009). · DOI · Paper page
  7. Franceschini, N. et al. Genome-wide association analysis of blood-pressure traits in African-ancestry individuals reveals common associated genes in African and non-African populations. Am. J. Hum. Genet. 93, 545–554 (2013). · DOI
  8. Liang, J. et al. Single-trait and multi-trait genome-wide association analyses identify novel loci for blood pressure in African-ancestry populations. PLoS Genet. 13, e1006728 (2017). · DOI
  9. Li, C. et al. Genome-wide association study meta-analysis of long-term average blood pressure in East Asians. Circ. Cardiovasc. Genet. 10, e001527 (2017).
  10. Warren, H. R. et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat. Genet. 49, 403–415 (2017). · DOI
  11. Sofer, T. et al. Genome-wide association study of blood pressure traits by Hispanic/Latino background: the Hispanic Community Health Study/Study of Latinos. Sci. Rep. 7, 10348 (2017). · DOI
  12. Adeyemo, A. et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet. 5, e1000564 (2009). · DOI
  13. Parmar, P. G. et al. International genome-wide association study consortium identifies novel loci associated with blood pressure in children and adolescents. Circ. Cardiovasc. Genet. 9, 266–278 (2016). · DOI
  14. Lu, X. et al. Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Hum. Mol. Genet. 24, 865–874 (2015). · DOI
  15. He, J. et al. Genome-wide association study identifies 8 novel loci associated with blood pressure responses to interventions in Han Chinese. Circ. Cardiovasc. Genet. 6, 598–607 (2013). · DOI
  16. Kato, N. et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat. Genet. 43, 531–538 (2011). · DOI
  17. Kato, N. et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat. Genet. 47, 1282–1293 (2015). · DOI
  18. Kelly, T. N. et al. Genome-wide association study meta-analysis reveals transethnic replication of mean arterial and pulse pressure loci. Hypertension 62, 853–859 (2013). · DOI · Paper page
  19. Wain, L. V. et al. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat. Genet. 43, 1005–1011 (2011). · DOI
  20. Kraja, A. T. et al. New blood pressure-associated loci identified in meta-analyses of 475,000 individuals. Circ. Cardiovasc. Genet. 10, e001778 (2017). · DOI
  21. Surendran, P. et al. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat. Genet. 48, 1151–1161 (2016). · DOI · Paper page
  22. Liu, C. et al. Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci. Nat. Genet. 48, 1162–1170 (2016). · DOI
  23. Wain, L. V. et al. Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney. Hypertension 70, e4–e19 (2017). · DOI
  24. Ehret, G. B. et al. The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals. Nat. Genet. 48, 1171–1184 (2016). · DOI
  25. Hoffmann, T. J. et al. Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. Nat. Genet. 49, 54–64 (2017). · DOI
  26. Lee, D. et al. A method to predict the impact of regulatory variants from DNA sequence. Nat. Genet. 47, 955–961 (2015). · DOI
  27. Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015). · DOI · Paper page
  28. Barbeira, A. N. et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat. Commun. 9, 1825 (2018). · DOI · Paper page
  29. Gamazon, E. R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091–1098 (2015). · DOI
  30. Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252 (2016). · DOI · Paper page
  31. Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016). · DOI · Paper page
  32. International Consortium for Blood Pressure Genome-Wide Association Studies et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103–109 (2011). · DOI · Paper page
  33. Ko, Y.-A. et al. Genetic-variation-driven gene-expression changes highlight genes with important functions for kidney disease. Am. J. Hum. Genet. 100, 940–953 (2017). · DOI
  34. Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015). · DOI · Paper page
  35. Gamazon, E. R. et al. Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat. Genet. 50, 956–967 (2018). · DOI · Paper page
  36. Matsuki, K., Hathaway, C. K., Lawrence, M. G., Smithies, O. & Kakoki, M. The role of transforming growth factor β1 in the regulation of blood pressure. Curr. Hypertens. Rev. 10, 223–238 (2014). · DOI
  37. Lavoie, P. et al. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J. Hypertens. 23, 1895–1903 (2005). · DOI
  38. Dubois, C. M., Laprise, M. H., Blanchette, F., Gentry, L. E. & Leduc, R. Processing of transforming growth factor beta 1 precursor by human furin convertase. J. Biol. Chem. 270, 10618–10624 (1995). · DOI
  39. Li, N. et al. Associations between genetic variations in the FURIN gene and hypertension. BMC Med. Genet. 11, 124 (2010). · DOI
  40. Ruschitzka, F. et al. Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial. Eur. Heart J. 38, 3282–3292 (2017). · DOI · Paper page
  41. Rippe, C. et al. Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway. Sci. Rep. 7, 1334 (2017). · DOI
  42. Bauersachs, J. et al. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc. Res. 37, 772–779 (1998). · DOI
  43. Ruetten, H., Zabel, U., Linz, W. & Schmidt, H. H. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ. Res. 85, 534–541 (1999). · DOI
  44. Protogerou, A. D. et al. Longitudinal changes in mean and pulse pressure, and all-cause mortality: data from 71,629 untreated normotensive individuals. Am. J. Hypertens. 30, 1093–1099 (2017). · DOI
  45. Yasuno, S. et al. Is pulse pressure a predictor of new-onset diabetes in high-risk hypertensive patients? Diabetes Care 33, 1122–1127 (2010). · DOI
  46. Said, M. A., Eppinga, R. N., Lipsic, E., Verweij, N. & van der Harst, P. Relationship of arterial stiffness index and pulse pressure with cardiovascular disease and mortality. J. Am. Heart Assoc. 7, e007621 (2018). · DOI
  47. Prenner, S. B. & Chirinos, J. A. Arterial stiffness in diabetes mellitus. Atherosclerosis 238, 370–379 (2015). · DOI
  48. Xu, M. et al. Diabetes and risk of arterial stiffness: a Mendelian randomization analysis. Diabetes 65, 1731–1740 (2016). · DOI
  49. Bhosale, S. D. et al. Serum proteomic profiling to identify biomarkers of premature carotid atherosclerosis. Sci. Rep. 8, 9209 (2018). · DOI
  50. Lee, J. H. et al. Association between CDH13 variants and cardiometabolic and vascular phenotypes in a Korean population. Yonsei. Med. J. 54, 1305–1312 (2013). · DOI
  51. Reschen, M. E., Lin, D., Chalisey, A., Soilleux, E. J. & O’Callaghan, C. A. Genetic and environmental risk factors for atherosclerosis regulate transcription of phosphatase and actin regulating gene PHACTR1. Atherosclerosis 250, 95–105 (2016). · DOI
  52. Jarray, R. et al. Disruption of phactr-1 pathway triggers pro-inflammatory and pro-atherogenic factors: new insights in atherosclerosis development. Biochimie 118, 151–161 (2015). · DOI
  53. Williams, C., Kingwell, B. A., Burke, K., McPherson, J. & Dart, A. M. Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype. Am. J. Clin. Nutr. 82, 26–31 (2005). · DOI
  54. Girelli, D. et al. The interaction between MTHFR 677 C→T genotype and folate status is a determinant of coronary atherosclerosis risk. J. Nutr. 133, 1281–1285 (2003). · DOI
  55. Bani, D. Relaxin: a pleiotropic hormone. Gen. Pharmacol. 28, 13–22 (1997). · DOI
  56. Grossman, J. & Frishman, W. H. Relaxin: a new approach for the treatment of acute congestive heart failure. Cardiol. Rev. 18, 305–312 (2010). · DOI
  57. Teichman, S. L. et al. Relaxin, a pleiotropic vasodilator for the treatment of heart failure. Heart. Fail. Rev. 14, 321–329 (2009). · DOI
  58. Teerlink, J. R. et al. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 373, 1429–1439 (2009). · DOI
  59. Bathgate, Ra. D. et al. Relaxin family peptides and their receptors. Physiol. Rev. 93, 405–480 (2013). · DOI · Paper page
  60. McNally, T. et al. Cloning and expression of the adenosine kinase gene from rat and human tissues. Biochem. Biophys. Res. Commun. 231, 645–650 (1997). · DOI
  61. Shryock, J. C. & Belardinelli, L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am. J. Cardiol. 79, 2–10 (1997). · DOI
  62. Böhm, M. Cardiac effects of adenosine. Mechanism of action, pathophysiologic and clinical significance. Klin. Wochenschr. 65, 487–499 (1987). · DOI
  63. Echavarría-Pinto, M. et al. Low coronary microcirculatory resistance associated with profound hypotension during intravenous adenosine infusion: implications for the functional assessment of coronary stenoses. Circ. Cardiovasc. Interv. 7, 35–42 (2014). · DOI
  64. Camm, A. J. & Garratt, C. J. Adenosine and supraventricular tachycardia. N. Engl. J. Med. 325, 1621–1629 (1991). · DOI
  65. Shen, F. M. & Su, D. F. The effect of adenosine on blood pressure variability in sinoaortic denervated rats is mediated by adenosine A2a-receptor. J. Cardiovasc. Pharmacol. 36, 681–686 (2000). · DOI
  66. Maass, P. G. et al. PDE3A mutations cause autosomal dominant hypertension with brachydactyly. Nat. Genet. 47, 647–653 (2015). · DOI · Paper page
  67. Houslay, M. Hypertension linked to PDE3A activation. Nat. Genet. 47, 562–563 (2015). · DOI
  68. Schuster, H. et al. A cross-over medication trial for patients with autosomal-dominant hypertension with brachydactyly. Kidney Int. 53, 167–172 (1998). · DOI
  69. Naraghi, R. et al. Neurovascular compression at the ventrolateral medulla in autosomal dominant hypertension and brachydactyly. Stroke 28, 1749–1754 (1997). · DOI
  70. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333–338 (2011). · DOI · Paper page
  71. Getman, D. K., Eubanks, J. H., Camp, S., Evans, G. A. & Taylor, P. The human gene encoding acetylcholinesterase is located on the long arm of chromosome 7. Am. J. Hum. Genet. 51, 170–177 (1992).
  72. Singer, W. et al. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J. Neurol. Neurosurg. Psychiatry 74, 1294–1298 (2003). · DOI
  73. Del Greco, M. F. et al. Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster. Hum. Mol. Genet. 20, 1660–1671 (2011). · DOI
  74. Flister, M. J. et al. Identifying multiple causative genes at a single GWAS locus. Genome Res. 23, 1996–2002 (2013). · DOI
  75. Brandt, S. & Jentsch, T. J. ClC-6 and ClC-7 are two novel broadly expressed members of the CLC chloride channel family. FEBS Lett. 377, 15–20 (1995). · DOI
  76. Park, J. et al. Comprehensive single cell RNAseq analysis of the kidney reveals novel cell types and unexpected cell plasticity. Preprint at https://www.biorxiv.org/content/early/2017/10/13/203125 (2017). · DOI
  77. Loh, P.-R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443–1448 (2016). · DOI · Paper page
  78. Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016). · DOI · Paper page
  79. Abraham, G. & Inouye, M. Fast principal component analysis of large-scale genome-wide data. PLoS One 9, e93766 (2014). · DOI
  80. Chawla, P. S. & Kochar, M. S. Effect of pain and nonsteroidal analgesics on blood pressure. WMJ 98, 22–25 (1999). 29.
  81. Maixner, W., Gracely, R. H., Zuniga, J. R., Humphrey, C. B. & Bloodworth, G. R. Cardiovascular and sensory responses to forearm ischemia and dynamic hand exercise. Am. J. Physiol. 259, R1156–R1163 (1990).
  82. Taylor, J. Y. et al. A genome-wide study of blood pressure in African Americans accounting for gene-smoking interaction. Sci. Rep. 6, 18812 (2016). · DOI
  83. Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011). · DOI · Paper page
  84. Carroll, R. J., Bastarache, L. & Denny, J. C. R. PheWAS: data analysis and plotting tools for phenome-wide association studies in the Renvironment. Bioinformatics 30, 2375–2376 (2014). · DOI
  85. Kuhn, M., Letunic, I., Jensen, L. J. & Bork, P. The SIDER database of drugs and side effects. Nucleic Acids Res. 44, D1075–D1079 (2016). · DOI · Paper page
  86. Cotto, K. C. et al. DGIdb 3.0: a redesign and expansion of the drug-gene interaction database. Nucleic Acids Res. 46, D1068–D1073 (2017). · DOI
  87. Li, Y. H. et al. Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics. Nucleic Acids Res. 46, D1121–D1127 (2018). · DOI

Cited by

Sorted by citations

Metadata

Authors
Understanding Society Scientific Group, Giri, A., International Consortium for Blood Pressure, Blood Pressure-International Consortium of Exome Chip Studies, Program, M. V., Hellwege, J. N., Keaton, J. M., Park, J., Qiu, C., Warren, H. R., Torstenson, E. S., Kovesdy, C. P., Sun, Y. V., Wilson, O. D., Robinson-Cohen, C., Roumie, C. L., Chung, C. P., Birdwell, K. A., Damrauer, S. M., DuVall, S. L., Klarin, D., Cho, K., Wang, Y., Evangelou, E., Cabrera, C. P., Wain, L. V., Shrestha, R., Mautz, B. S., Akwo, E. A., Sargurupremraj, M., Debette, S., Boehnke, M., Scott, L. J., Luan, J., Zhao, J.-H., Willems, S. M., Thériault, S., Shah, N., Oldmeadow, C., Almgren, P., Li-Gao, R., Verweij, N., Boutin, T. S., Mangino, M., Ntalla, I., Feofanova, E., Surendran, P., Cook, J. P., Karthikeyan, S., Lahrouchi, N., Liu, C., Sepúlveda, N., Richardson, T. G., Kraja, A., Amouyel, P., Farrall, M., Poulter, N. R., Laakso, M., Zeggini, E., Sever, P., Scott, R. A., Langenberg, C., Wareham, N. J., Conen, D., Palmer, C. N. A., Attia, J., Chasman, D. I., Ridker, P. M., Melander, O., Mook-Kanamori, D. O., Harst, P. V. D., Cucca, F., Schlessinger, D., Hayward, C., Spector, T. D., Jarvelin, M.-R., Hennig, B. J., Timpson, N. J., Wei, W.-Q., Smith, J. C., Xu, Y., Matheny, M. E., Siew, E. E., Lindgren, C., Herzig, K.-H., Dedoussis, G., Denny, J. C., Psaty, B. M., Howson, J. M. M., Munroe, P. B., Newton-Cheh, C., Caulfield, M. J., Elliott, P., Gaziano, J. M., Concato, J., Wilson, P. W. F., Tsao, P. S., Velez Edwards, D. R., Susztak, K., O’Donnell, C. J., Hung, A. M., & Edwards, T. L.
ORCID
Venue
Nature Genetics
Publisher
Springer Science and Business Media LLC
Published
2018-12-21
Volume
51
Issue
1
Pages
51-62
ISSN
  • 1061-4036
  • 1546-1718
DOI
10.1038/s41588-018-0303-9
PMC
PMC6365102
Cited by
459
References
12
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review